Evolution Venture Partners
Evolution Venture Partners is a New York-based healthcare investment banking boutique founded in 2013 by managing partners Philip Taub and John Andreadis, providing capital raising, M&A advisory, strategic partnering, and VC portfolio solutions to life sciences, biotechnology, and health & wellness companies.
- Company typePrivate
- Founded2013
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Evolution Venture Partners does
Evolution Venture Partners (EVP) is a New York-based healthcare investment banking boutique operating as a registered trade name of J. Alden Associates, Inc., founded in 2013. The firm is structured around two managing partners, Philip Taub and John Andreadis, who together maintain a 25+ year track record in life sciences advisory spanning over 150 public and private offerings (Taub) and 100+ financings (Andreadis). EVP serves early to mid-stage companies across healthcare, biotechnology, health and wellness, and adjacent technology sectors, as well as venture capital funds and their portfolio companies, and public companies seeking additional capital or M&A activity.
EVP's product set consists of four core advisory offerings: Capital Raising (institutional fundings via VC, private equity, corporate strategics, and family offices), Mergers & Acquisitions Advisory (domestic and international transaction design and execution), Strategic Partnering/in-licensing (asset pipeline assessment, portfolio showcasing, and parallel non-dilutive capital processes), and VC Portfolio Solutions (follow-on financings, strategic partnering sourcing, M&A, and wind-down support). All securities transactions are routed through American Global Wealth Management, a FINRA/SIPC-registered broker-dealer.
EVP generates revenue through transaction-based advisory fees, success fees on completed deals, and bespoke advisory retainers negotiated per mandate. The firm has a headcount of 1-10 employees, uses a sales-led go-to-market model driven entirely by partner relationships and referral networks, and has no proprietary technology platform, no patents, and no venture capital backing. The firm is privately held with no disclosed ownership structure beyond its parent entity J. Alden Associates, Inc.
Evolution Venture Partners firmographics
Firmographics- Name
- Evolution Venture Partners
- Legal name
- J. Alden Associates, Inc.
- Website
- https://evovp.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Evolution Venture Partners is a New York-based healthcare investment banking boutique founded in 2013 by managing partners Philip Taub and John Andreadis, providing capital raising, M&A advisory, strategic partnering, and VC portfolio solutions to life sciences, biotechnology, and health & wellness companies.
- Ownership category
- akta.pro rank
Evolution Venture Partners industry classification
Industry- Product category
- Healthcare Investment Banking
- NAICS
- Investment Banking and Securities Intermediation (523150)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Venture Capital Fundraising Placement (FSAEALAC)
Keywords
Where Evolution Venture Partners is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Evolution Venture Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Investment Banking Advisory: EVP provides investment banking services including capital raising, M&A advisory, and strategic partnering for healthcare, biotechnology, and life sciences companies. Revenue is generated through transaction-based fees, success fees on completed deals, and advisory retainers.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Evolution Venture Partners product offering
Product offeringCore offering
Evolution Venture Partners is a healthcare investment banking boutique that provides advisory services to life sciences, biotechnology, and health & wellness companies. Its core services include capital raising (venture financings, IPO preparation, and public market capital access), mergers & acquisitions advisory, strategic partnering and in-licensing support, and venture capital portfolio solutions including follow-on financings and wind-down advisory. Securities transactions are executed through American Global Wealth Management, with the firm operating as J. Alden Associates, Inc.
Product overview
Evolution Venture Partners is a healthcare investment banking boutique offering advisory services. The firm operates as a single-service model providing investment banking services to the life sciences, biotechnology, and health & wellness industries. The core offerings consist of Capital Raising, Mergers & Acquisitions Advisory, Strategic Partnering Services, and VC Portfolio Solutions. These services are delivered through the managing partners and a network of advisors without a platform or software product architecture.
Differentiator
Problem solved
Functional benefit
Products and services
- Capital Raising
Companies that use Evolution Venture Partners
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles3 records
Evolution Venture Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Evolution Venture Partners partnerships and signals
Strategic signalScale indicators3 records
Recent moves3 records
Evolution Venture Partners competitors and assessment
Company assessmentDirect peers
- EF Hutton: Small/mid-cap investment bank with active healthcare and biotech coverage, providing capital raising and advisory. Overlaps with EVP in target client size, healthcare specialization, and transaction types.
- A.G.P. / Alliance Global Partners: Healthcare-focused boutique investment bank and broker-dealer serving small/mid-cap biotech issuers with capital raises and advisory. Comparable to EVP in target client profile, healthcare specialization, and transaction types (PIPEs, follow-ons, M&A).
- Maxim Group: Healthcare-specialist boutique investment bank providing capital raising and advisory services to emerging life sciences and healthcare companies. Closely comparable to EVP's target market, deal sizes, and sales-led model.
- H.C. Wainwright & Co. Healthcare-focused boutique investment bank providing capital markets advisory, equity raises, and M&A to small/mid-cap biotech and life sciences companies. Highly comparable business model and client base to EVP, with a similarly specialized healthcare focus.
- WestPark Capital: Healthcare-active boutique investment bank providing capital raising, advisory, and institutional research to small/mid-cap life sciences companies. Comparable in service scope and target issuer profile to EVP.
- Roth Capital Partners: Boutique investment bank with strong small/mid-cap and healthcare practice, providing capital raising, M&A advisory, and equity research. Comparable in scale, sector focus, and service mix to EVP.
- Aegis Capital Corp. Boutique investment bank and broker-dealer with healthcare and life sciences focus, providing capital markets execution and advisory. Comparable to EVP in boutique scale and biotech client base.
Broad incumbents
- Jefferies Healthcare Group: Global investment bank with a large healthcare franchise advising biotech and pharma on capital markets and M&A. Overlaps with EVP at the larger end of EVP's mandate range but offers much broader global distribution.
- Piper Sandler Healthcare Group: Mid-market full-service investment bank with a dedicated healthcare group covering biotech, medtech, and life sciences. Larger incumbent competing for many of the same healthcare advisory mandates EVP targets, but with broader sector and product coverage.
- Leerink Partners (now SVB Securities / Leerink): Healthcare-dedicated investment bank (now part of SVB Securities/Leerink franchise) providing advisory and capital markets services to biotech and life sciences companies. Larger incumbent peer overlapping directly with EVP's healthcare focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Customer concentration
Evolution Venture Partners social profiles
Digital presenceEvolution Venture Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evolution Venture Partners leadership team
Management profileNumber of profiles
Profiles3 records
Evolution Venture Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evolution Venture Partners M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evolution Venture Partners
What does Evolution Venture Partners do?
Evolution Venture Partners is a healthcare investment banking boutique that provides advisory services to life sciences, biotechnology, and health & wellness companies. Its core services include capital raising (venture financings, IPO preparation, and public market capital access), mergers & acquisitions advisory, strategic partnering and in-licensing support, and venture capital portfolio solutions including follow-on financings and wind-down advisory. Securities transactions are executed through American Global Wealth Management, with the firm operating as J. Alden Associates, Inc.
Is Evolution Venture Partners a public or private company?
Evolution Venture Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Evolution Venture Partners founded?
Evolution Venture Partners was founded in 2013. It employs 1 to 10 people.
Where is Evolution Venture Partners based?
Evolution Venture Partners is headquartered in New York, United States, in the North America region.
How does Evolution Venture Partners make money?
One revenue line is on record: investment Banking Advisory.
Who are Evolution Venture Partners's main competitors?
Direct peers on record are EF Hutton, A.G.P. / Alliance Global Partners, Maxim Group, H.C. Wainwright & Co., WestPark Capital, Roth Capital Partners and Aegis Capital Corp.. Broad incumbents are Jefferies Healthcare Group, Piper Sandler Healthcare Group and Leerink Partners (now SVB Securities / Leerink).
Does Evolution Venture Partners have an API?
No public API is recorded for Evolution Venture Partners.
What industry is Evolution Venture Partners in?
Evolution Venture Partners's product category is Healthcare Investment Banking. Its primary akta.pro industry code is FSAEALAC, Venture Capital Fundraising Placement. Its NAICS code is 523150 and its SIC code is 6211.